Please Wait
Applying Filters...
menu
    • menu
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Northera

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Chongqing Shenghuaxi Pharma. Co., Ltd
    China
    		 CHONGQING SHENGHUAXI PHARMACEUTICAL CO. , LTD. 218MF10680 Droxidopa 2006-08-11 2006-08-11 Renjiawan, Dashiba, Nan an Chongqing 40006, China
    26/09/2024 Chongqing Shenghuaxi Pharma. Co., Ltd
    China
    		 Chongqing Shenghuaxi Pharmaceutical Co. ,Ltd 218MF10452 Droxidopa 2006-04-27 2007-02-13 Rejiawan, Dashiba, Nan an, Chongqing China